/ACNNF
ACNNF Stock - AusCann Group Holdings Ltd
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00-15.56%
$0.00 (-15.56%) • Sep 9
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.20
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.89
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ACNNF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.77
52W High$0.11
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $1.55M | $1.51M | $1.65M | $3,204 | $670,606 |
| Gross Profit | $1.51M | $-1,671,000 | $-5,527,000 | $-2,073,000 | $614,364 |
| Gross Margin | 97.1% | -110.4% | -335.8% | -64700.4% | 91.6% |
| Operating Income | $-1,381,000 | $-6,908,000 | $-9,660,000 | $-7,534,000 | $-6,497,000 |
| Net Income | $-10,816,000 | $-26,358,000 | $-8,641,000 | $-7,076,000 | $-7,649,000 |
| Net Margin | -697.4% | -1741.0% | -525.0% | -220848.9% | -1140.6% |
| EPS | $-0.02 | $-0.06 | $-0.02 | $-0.02 | $-0.02 |
Company Overview
AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ACNNFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q1 2024
EPS Surprise History
Q2 20
No data
Q4 20
No data
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q1 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 4, 2025 | — | — | — | — |
Q2 2025 | Apr 1, 2025 | — | — | — | — |
Q3 2024 | Sep 25, 2024 | — | — | — | — |
Q3 2024 | Aug 30, 2024 | — | — | — | — |
Q2 2024 | Apr 3, 2024 | — | — | — | — |
Q1 2024 | Jan 30, 2024 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.03 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 30, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.01 | — | — |
Q4 2019 | Dec 30, 2019 | — | $-0.01 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.01 | — | — |
Q4 2018 | Dec 30, 2018 | — | $-0.01 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.01 | — | — |
Q4 2017 | Dec 30, 2017 | — | $-0.01 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.04 | — | — |
Q4 2016 | Dec 30, 2016 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ACNNF
What is ACNNF's current stock price?
AusCann Group Holdings Ltd (ACNNF) is currently trading at $0.00 per share. The stock has moved -15.56% today.
What is the analyst price target for ACNNF?
No analyst price targets are currently available for this stock.
What sector is AusCann Group Holdings Ltd in?
AusCann Group Holdings Ltd operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is ACNNF's market cap?
AusCann Group Holdings Ltd has a market capitalization of $0.00 billion, making it a small-cap company.
Does ACNNF pay dividends?
No, AusCann Group Holdings Ltd does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCANB
Can B Corp.
$0.02
Mkt Cap: $0.0B
CBDNF
CBD Global Sciences Inc.
$0.04
Mkt Cap: $0.0B
CIMVF
Pideka Group Inc.
$0.01
Mkt Cap: $0.0B
ETRGF
Entourage Health Corp.
$0.00
Mkt Cap: $0.0B
IWINF
Irwin Naturals Inc.
$0.50
Mkt Cap: $0.0B
KALO
Kallo Inc.
$0.00
Mkt Cap: $0.0B
PARNF
Parnell Pharmaceuticals Holdings Ltd
$0.08
Mkt Cap: $0.0B
PRXTF
Pure Extracts Technologies Corp.
$0.01
Mkt Cap: $0.0B
RCMW
RCMW Group, Inc.
$0.00
Mkt Cap: $0.0B
SILFF
Silo Wellness Inc.
$0.01
Mkt Cap: $0.0B
Explore stocks similar to ACNNF for comparison